drugset / Trial / NCT02948322

Cardiac (CMRI) Assessment of Acromegaly

NCT02948322

Non-randomizedParallel-groupSingle-blindOther

Summary

In this study, the investigators will evaluate the cardiac structure and function, focusing on the myocardial water content and interstitial fibrosis, in patients with active acromegaly in comparison with 1) healthy volunteers, 2) the same acromegalic patients that have received efficient therapy. The investigators hypothesize that the myocardial water content in acromegaly is increased as these patients present with sodium and water retention and that this myocardial water infiltration will improve with efficient treatment of the disease. They will thus assess using CMRI, this parameter by measuring the myocardial transverse relaxation time (T2), reflecting water content in the myocardium.

Timeline

Start
2014-12
Primary completion
2017-06-09
Completion
2019-02-28

Drugs

EvaluationDrugModalityDoseRoute
Background Gadolinium Diagnostic / imaging agent

Indications